Table 5.
Comparison of PR3 levels in different clinical subgroups
| Fisher's PLSD, P-value | |
|---|---|
| Vasc-pat versus HBD | <0·0001 (s.) |
| Vasc-pat versus DC | <0·0001 (s.) |
| Vasc-pat, remission versus smouldering | 0·21 (n.s.) |
| Vasc-pat, severe outcome versus non-severe outcome | 0·44 (n.s.) |
| Vasc-pat, relapse versus no relapse | 0·74 (n.s.) |
Vasc-pat = all vasculitis patients. HBD = healthy blood donors. DC = disease controls. Severe outcome = severe organ damage, start in dialysis or death due to vasculitic complications during 6 years’ follow-up. Relapse = at least one relapse during 6 years’ follow up. n.s. = non-significant, s. = significant.